Development and Internal Validation of a Nomogram for Predicting Significant Prostate Cancer in Patients with PSA Level less than 20 Ng/Ml

Stojadinovic Miroslav, Stojadinovic Dobrivoje, Pantic Damnjan, Stojadinovic Miroslav, Stojadinovic Milorad and Stojadinovic Dobrivoje
Additional contact information
Pantic Damnjan: Department of Urology, Clinical Centre Kragujevac, Clinic of Urology and Nephrology, Kragujevac, Serbia
Stojadinovic Milorad: University of Kragujevac, Faculty of Medical Sciences, Serbia
Stojadinovic Dobrivoje: Department of Anatomy, University of Kragujevac, Faculty of Medical Sciences, Serbia

Cancer Therapy & Oncology International Journal, 2019, vol. 14, issue 3, 50-57

Abstract: To develop and validate internally the nomogram that allows an individual assessment of a risk of harboring significant prostate cancer (PCa) in patients with prostate-specific antigen (PSA) level less than 20 ng/ml, prior to initial and repeat biopsy in Serbian population.

Keywords: juniper publishers:oncology journals; oncology research journals; oncology journal articles; oncology and cancer case reports; oncology journal of clinical and experimental cancer research; open access; open access journals; Oncology International Journal; juniper publishers reivew (search for similar items in EconPapers)
Date: 2019
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://juniperpublishers.com/ctoij/pdf/CTOIJ.MS.ID.555887.pdf (application/pdf)
https://juniperpublishers.com/ctoij/CTOIJ.MS.ID.555887.php (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:adp:jctoij:v:14:y:2019:i:3:p:50-57

DOI: 10.19080/CTOIJ.2019.14.555887

Access Statistics for this article

Cancer Therapy & Oncology International Journal is currently edited by Sophia Mathis

More articles in Cancer Therapy & Oncology International Journal from Juniper Publishers Inc.
Bibliographic data for series maintained by Robert Thomas ().